RT Journal Article
SR Electronic
T1 Lung ultrasound findings in patients with novel SARS-CoV2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.18.20105775
DO 10.1101/2020.05.18.20105775
A1 Haaksma, Mark E.
A1 Heldeweg, Micah L. A.
A1 Matta, Jorge E. Lopez
A1 Smit, Jasper M.
A1 van Trigt, Jessica D.
A1 Nooitgedacht, Jip S.
A1 Kraemer, Carlos V. Elzo
A1 Girbes, Armand R.J.
A1 Heunks, Leo
A1 van Westerloo, David J.
A1 Tuinman, Pieter R.
YR 2020
UL http://medrxiv.org/content/early/2020/05/21/2020.05.18.20105775.abstract
AB Background Over 2 million people worldwide have been infected with Severe Acute Respiratory Distress Syndrome Corona Virus 2 (SARS CoV2). Lung ultrasound has been proposed to diagnose and it. However, little is known about ultrasound findings in these patients. Our aim is to present an overview of lung ultrasound characteristics in critically ill patients with SARS CoV2 pneumonia overall and in relation to the duration of symptoms and clinical parameters.Methods On the Intensive Care Unit of two academic hospitals, adult patients who tested positive for SARS-CoV2 were included. Images were analyzed for pleural line characteristics, number and appearance of B-lines, BLUE-profiles (Bedside Lung Ultrasound in Emergency), pathology in the PLAPS (Postero Lateral Alveolar and Pleural Syndrome) point and a LUS-score (lung ultrasound). The primary outcomes were frequencies, percentages and differences in lung ultrasound findings overall and between short (≤14 days) and long (>14 days) duration of symptoms and their correlation with clinical parameters.Results In this pilot observational study, 61 patients were included with 75 examinations for analysis. The most prevalent ultrasound findings were decreased lung sliding (36%), thickening of the pleural line (42%) and a C-profile per view (37%). Patients with “long” duration of symptoms presented more frequently with a thickened and irregular pleural line (21% (32) vs 9% (11), p=.01), C-profile per patient (47% (18) vs. 25% (8), p=.01) and pleural effusion (19% (14) vs 5% (3), p=.02) compared to patients with short duration of symptoms. Lung ultrasound findings did not correlate with P/F ratio, fluid balance or dynamic compliance, with the exception of the LUS-score and dynamic compliance (R2=0.27, p=.02).Conclusion SARS CoV2 results in significant ultrasound changes, with decreased lung sliding, thickening of the pleural line and a C-profile being the most observed. With time, a thickened and irregular pleural line, C-profile and pleural effusion become more common findings.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNL8540Funding StatementNo funding was received for this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be made available for other researchers on reasonable request, upon publication in an indexed journal.